SEC Form 4 · accession 0000914190-15-000299
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Robert M. Gavin
Officer — Senior V.P. Protein Platforms
Period of report
Aug 7, 2015
Accepted (ET)
Aug 11, 2015 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $108.49 | Aug 7, 2015 | A | 12,500 | A | — | Aug 7, 2022 | Common Stock | 12,500 | 12,500 | D |
| Stock Option (Right to Buy)F7 | $108.49 | Aug 7, 2015 | A | 6,250 | A | — | Aug 7, 2022 | Common Stock | 6,250 | 6,250 | D |
| Restricted Stock UnitsF6,F7 | — | Aug 7, 2015 | A | 1,000 | A | — | — | Common Stock | 1,000 | 1,000 | D |
| Stock Option (Right to Buy)F1 | $93.32 | holding | — | — | — | — | Jul 31, 2021 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F2 | $93.32 | holding | — | — | — | — | Jul 31, 2021 | Common Stock | 50,000 | 50,000 | D |
| Stock Option (Right to Buy)F3 | $90.25 | holding | — | — | — | — | Nov 30, 2021 | Common Stock | 5,000 | 5,000 | D |
| Restricted Stock UnitsF4 | — | holding | — | — | — | — | — | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F12,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
- F2The options vest if certain performance goals are achieved for calendar 2016.
- F31,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
- F4Vests in full or in part if certain performance goals are achieved for calendar 2016 (previously reported in Table I).
- F53,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F6Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F7Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.